Pulling SEC filings + quote and writing the call…
Pulling SEC filings + quote and writing the call…
Elevance Health, Inc.
Last earnings +0.0% on 2026-04-22
Revenue grew 12.5% YoY; but thin net margin (2.8%).
Rules-based read computed from SEC figures — no Anthropic key set. Add ANTHROPIC_API_KEY to .env.local for a full Claude analysis.
Elevance Health, Inc. shows $199B in FY2025 revenue (+12.5% YoY), a 2.8% net margin, and 12.9% ROE.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro$19/mo · cancel anytime
Sources: SEC EDGAR (CIK 0001156039, latest 10-Q filed 2026-04-22) · EODHD · rules-based read · as of 6/17/2026, 7:29:34 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $139B | $157B | $171B | $177B | $199B |
| Gross profit | — | — | — | — | — |
| Operating income | $7.56B | $8.28B | $8.50B | $7.86B | $7.20B |
| Net income | $6.16B | $5.89B | $5.99B | $5.98B | $5.66B |
| Diluted EPS | $24.95 | $24.28 | $25.22 | $25.68 | $25.21 |
| Net margin | 4.4% | 3.8% | 3.5% | 3.4% | 2.8% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
58 tracked peers · median
Source: EODHD. Yield = trailing-12-month dividends ÷ price.
Last 90 days: 0 open-market buys · 3 sales
| 2026-06-12 | Penczek Ronald W CAO & Controller | Sell | 369.00 @ $403.16 | $149K |
| 2026-06-11 | Dixon Robert L JR Director | Sell | 151.00 @ $401.77 | $60.7K |
| 2026-05-19 | Penczek Ronald W CAO & Controller | Exercise | 654.00 @ $271.27 | $177K |
| 2026-05-19 | Penczek Ronald W CAO & Controller | Exercise | 877.00 @ $311.48 | $273K |
| 2026-05-19 | Penczek Ronald W CAO & Controller | Sell | 1.53K @ $403.13 | $617K |
| 2026-05-13 | STRABLE-SOETHOUT DEANNA D Director | Award | 563.00 | |
| 2026-05-13 | SCHULMAN AMY W Director | Award | 563.00 | |
| 2026-05-13 | Schneider Ryan M. Director | Award | 563.00 | |
| 2026-05-13 | PERU RAMIRO G Director | Award | 563.00 | |
| 2026-05-13 | Neri Antonio F Director | Award | 563.00 |